Collect the serum sample
A fasting blood sample is collected and the serum is shipped to the laboratory for analysis.
Secure loading
Preparing your page…
Please wait while the latest information is loaded.
Please wait while the latest information is loaded.
SeroMark-1 combines advanced serum phospholipid profiling with predictive analytics to support accurate, reproducible prostate cancer risk assessment and doctor-guided follow-up.
Blood-based screening aid · Four-day laboratory turnaround from sample receipt · Doctor-guided interpretation
Indian study population
Advanced testing. Better outcomes.
The result translates a panel of serum biomarker signals into a structured index that a qualified doctor interprets alongside your history and other findings.
Low risk band
Low0.00–0.34
Borderline0.35–0.49
Elevated0.50–1.00
Demonstration only. A healthcare professional must interpret every result in its full clinical context.
A controlled pathway from fasting serum collection through quality checks, predictive analysis, reporting, and doctor review.
A fasting blood sample is collected and the serum is shipped to the laboratory for analysis.
The laboratory checks the sample against quality-control parameters and processes the data through the bioinformatics pipeline.
The report is released electronically or in hard copy for interpretation and follow-up with a doctor.
In the Indian study population identified in Nutech's approved material, the multi-protein SeroMark-1 panel reported higher values across these measured performance metrics.
Study-population results do not guarantee an individual outcome. SeroMark-1 remains a screening aid and does not replace PSA, examination, imaging, biopsy, or doctor judgement.
| Performance metric | PSA test | SeroMark-1 |
|---|---|---|
| Sensitivity | 62.0% | 79.7% |
| Specificity | 70.0% | 87.9% |
| Overall classification accuracy | 65.0% | 83.6% |
| ROC AUC | 0.71 | 0.927 |
Nutech combines clinical-performance evidence, objective predictive analytics, more than a decade of biomarker experience, and nationwide sample coordination.
Robust performance reported in the Indian study population.
Multivariate analytics for consistent risk classification.
Sample coordination supported across India.
Check the screening criteria, find a collection location, or speak with the Nutech team before you decide.